X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1748) 1748
Publication (239) 239
Book Chapter (11) 11
Book Review (7) 7
Dissertation (7) 7
Conference Proceeding (6) 6
Magazine Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1550) 1550
adamts13 protein (1234) 1234
index medicus (1010) 1010
hematology (991) 991
thrombotic thrombocytopenic purpura (799) 799
female (779) 779
male (682) 682
adamts13 (655) 655
factor-cleaving protease (642) 642
von-willebrand-factor (595) 595
von willebrand factor (560) 560
adult (548) 548
von willebrand factor - metabolism (543) 543
middle aged (466) 466
adam proteins - blood (402) 402
peripheral vascular disease (389) 389
hemolytic-uremic syndrome (369) 369
thrombocytopenic purpura (356) 356
purpura, thrombotic thrombocytopenic - therapy (331) 331
purpura, thrombotic thrombocytopenic - diagnosis (320) 320
purpura, thrombotic thrombocytopenic - blood (303) 303
aged (295) 295
adam proteins - metabolism (272) 272
plasma exchange (270) 270
adam proteins (250) 250
animals (239) 239
hemic and lymphatic diseases (230) 230
plasma (226) 226
adam proteins - genetics (210) 210
plasma-exchange (192) 192
disease (188) 188
adolescent (187) 187
adam proteins - deficiency (185) 185
ttp (179) 179
adam proteins - immunology (176) 176
purpura, thrombotic thrombocytopenic - genetics (174) 174
cleavage (166) 166
vonwillebrand-factor (163) 163
mutations (157) 157
rituximab (154) 154
treatment outcome (153) 153
autoantibodies - blood (151) 151
thrombosis (148) 148
risk factors (147) 147
thrombotic microangiopathy (146) 146
von willebrand factor - chemistry (146) 146
abridged index medicus (145) 145
adamts-13 (145) 145
young adult (143) 143
proteolysis (142) 142
diagnosis (141) 141
antibodies (140) 140
mutation (139) 139
mice (137) 137
child (133) 133
deficiency (133) 133
analysis (132) 132
microangiopathies (128) 128
biomarkers - blood (126) 126
von willebrand factor - genetics (126) 126
factor multimers (125) 125
factor-viii (125) 125
purpura, thrombotic thrombocytopenic - immunology (124) 124
autoantibodies (122) 122
purpura, thrombotic thrombocytopenic - etiology (122) 122
pregnancy (119) 119
vwf (118) 118
von willebrand factor - analysis (117) 117
metalloendopeptidases - metabolism (116) 116
recurrence (115) 115
case-control studies (113) 113
purpura, thrombotic thrombocytopenic - enzymology (113) 113
endothelial-cells (112) 112
diagnosis, differential (111) 111
adamts13 activity (110) 110
metalloendopeptidases - deficiency (105) 105
metalloendopeptidases - blood (103) 103
purpura, thrombotic thrombocytopenic - drug therapy (103) 103
metalloprotease (99) 99
platelet count (99) 99
medicine & public health (96) 96
child, preschool (92) 92
purpura (92) 92
adamts13 protein - blood (91) 91
article (91) 91
metalloendopeptidases - genetics (91) 91
platelets (90) 90
purpura, thrombotic thrombocytopenic - complications (90) 90
prognosis (88) 88
care and treatment (87) 87
retrospective studies (85) 85
inflammation (84) 84
time factors (84) 84
risk (83) 83
protein binding (81) 81
thrombocytopenia (81) 81
vonwillebrand-factor multimers (81) 81
enzyme-linked immunosorbent assay (78) 78
blood platelets - metabolism (76) 76
protein structure, tertiary (76) 76
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1669) 1669
Japanese (30) 30
Chinese (20) 20
German (12) 12
French (11) 11
Spanish (5) 5
Danish (2) 2
Dutch (2) 2
Swedish (2) 2
Hebrew (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 02/2017, Volume 15, Issue 2, pp. 312 - 322
Essentials An international collaboration provides a consensus for clinical definitions. This concerns thrombotic microangiopathies and thrombotic... 
diagnosis, differential | thrombotic thrombocytopenic purpura | thrombotic microangiopathy | thrombocytopenia | ADAMTS‐13 protein, human | ADAMTS-13 protein, human | MANAGEMENT | ANTI-ADAMTS13 ANTIBODIES | HEMOLYTIC-UREMIC-SYNDROME | IGG ANTIBODIES | FACTOR-CLEAVING PROTEASE | PLASMA-EXCHANGE | ACUTE EPISODES | ADAMTS13 ACTIVITY | RITUXIMAB | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | UPSHAW-SCHULMAN SYNDROME | Recurrence | Humans | ADAMTS13 Protein - blood | Fibrin - chemistry | Societies, Medical | Adult | Female | Hemolytic-Uremic Syndrome - diagnosis | Child | von Willebrand Factor - metabolism | Hemolysis | Diagnosis, Differential | Hematology - standards | Terminology as Topic | Treatment Outcome | Inflammation | Purpura, Thrombotic Thrombocytopenic - diagnosis | Remission Induction | Consensus | Complement System Proteins | Platelet Aggregation | Pregnancy | Platelet Count | Blood Platelets - metabolism | Erythrocytes - metabolism | Thrombotic Microangiopathies - diagnosis | Thrombocytopenic purpura | Enzymes | Terms and phrases | Anemia | Liver | Von Willebrand factor | Working groups | Standardization | Thrombocytopenia | Thrombotic microangiopathy | Clinical trials | Disseminated intravascular coagulation | Transplantation | Thrombotic thrombocytopenic purpura | Hemolytic anemia | Purpura | Eclampsia | Remission | Platelets | Autoimmune diseases
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 12/2014, Volume 111, Issue 52, pp. 18584 - 18589
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 10/2017, Volume 15, Issue 10, pp. 1889 - 1900
Summary Thrombotic thrombocytopenic purpura (TTP), a potentially fatal clinical syndrome, is primarily caused by autoantibodies against the von Willebrand... 
diagnosis | therapeutics | pathology | thrombotic microangiopathies | von Willebrand factor | HEMOLYTIC-UREMIC-SYNDROME | VON-WILLEBRAND-FACTOR | FACTOR-CLEAVING PROTEASE | MEDIATED GENE-THERAPY | PLASMA-EXCHANGE THERAPY | ADAMTS13 ACTIVITY | DISSEMINATED INTRAVASCULAR COAGULATION | ADVERSE-REACTIONS SONAR | RENAL-FAILURE | PERIPHERAL VASCULAR DISEASE | MALIGNANT HYPERTENSION | HEMATOLOGY | Recombinant Proteins - therapeutic use | Genetic Therapy | Predictive Value of Tests | Autoantibodies - blood | Humans | Plasma Exchange | ADAMTS13 Protein - blood | ADAMTS13 Protein - immunology | Hemostasis | Immunotherapy | Thrombocytopenia - therapy | Diagnosis, Differential | ADAMTS13 Protein - therapeutic use | Risk Factors | Treatment Outcome | Purpura, Thrombotic Thrombocytopenic - diagnosis | Purpura, Thrombotic Thrombocytopenic - epidemiology | Thrombocytopenia - blood | ADAMTS13 Protein - genetics | Anemia, Hemolytic - therapy | Anemia, Hemolytic - diagnosis | Thrombocytopenia - diagnosis | Purpura, Thrombotic Thrombocytopenic - therapy | Anemia, Hemolytic - blood | Purpura, Thrombotic Thrombocytopenic - blood | Autoimmunity | Autoantibodies | Anemia | Development and progression | Homeopathy | Materia medica and therapeutics | Thrombocytopenic purpura | Haptoglobin | Therapeutics | Von Willebrand factor | Hemoglobin | Diagnosis | Health aspects | Corticoids | Plasma | Cyclosporins | Pathogenesis | Prophylaxis | Antagonists | Splenectomy | Hemolytic anemia | Remission | Metalloproteinase | Thrombocytopenia | Thrombotic microangiopathy | Hemolytic uremic syndrome | Immunomodulation | Rituximab | Morbidity | L-Lactate dehydrogenase | Cyclophosphamide | Purpura | Lactic acid | Gene therapy | Platelets | Pathology | Thrombotic Microangiopathies | von Willebrand Factor
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 02/2018, Volume 16, Issue 2, pp. 378 - 388
Journal Article
Journal Article
Seminars in immunopathology, ISSN 1863-2297, 2012, Volume 34, Issue 1, pp. 93 - 106
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2016, Volume 11, Issue 8, p. e0160388
Thrombotic thrombocytopenic purpura (TTP) is a life-threatening thrombotic microangiopathy linked to a deficiency in the metalloprotease ADAMTS13. In the... 
VONWILLEBRAND-FACTOR | MYOCARDIAL-INFARCTION | VWF | MULTIDISCIPLINARY SCIENCES | IN-VIVO | MICE | VON-WILLEBRAND-FACTOR | ISCHEMIC-STROKE | FACTOR-CLEAVING PROTEASE | UPSHAW-SCHULMAN SYNDROME | DEFICIENCY | Recombinant Proteins - therapeutic use | Epitope Mapping | Humans | Protein Multimerization | Antibodies, Monoclonal - therapeutic use | Male | von Willebrand Factor - genetics | Recombinant Proteins - biosynthesis | Antigen-Antibody Reactions | ADAMTS13 Protein - blood | Recombinant Proteins - isolation & purification | ADAMTS13 Protein - immunology | Purpura, Thrombotic Thrombocytopenic - drug therapy | Female | Antibodies, Monoclonal - immunology | Disease Models, Animal | Purpura, Thrombotic Thrombocytopenic - metabolism | von Willebrand Factor - metabolism | Reproducibility of Results | Enzyme-Linked Immunosorbent Assay | ADAMTS13 Protein - metabolism | Mice, Knockout | Antibodies, Monoclonal - genetics | Purpura, Thrombotic Thrombocytopenic - pathology | Animals | Platelet Count | Recombinant Proteins - immunology | von Willebrand Factor - chemistry | ADAMTS13 Protein - genetics | Mice | Antibodies, Monoclonal - metabolism | Viral antibodies | Thrombocytopenic purpura | Care and treatment | Von Willebrand factor | Antibodies | Physiological aspects | Genetic aspects | Research | Diagnosis | Thrombotic microangiopathy | Antigens | Animal models | Drug delivery systems | Congenital diseases | Heart attacks | Laboratories | Injection | Thrombosis | Blood clots | Thrombotic thrombocytopenic purpura | Ischemia | Rodents | Medical prognosis | Preeclampsia | Monoclonal antibodies | Life sciences | Metalloproteinase | Mutation | Inhibition | Health risk assessment | Enzyme-linked immunosorbent assay
Journal Article
Journal Article